These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 33311590)

  • 81. LINC00543 promotes colorectal cancer metastasis by driving EMT and inducing the M2 polarization of tumor associated macrophages.
    Zheng J; Dou R; Zhang X; Zhong B; Fang C; Xu Q; Di Z; Huang S; Lin Z; Song J; Wang S; Xiong B
    J Transl Med; 2023 Feb; 21(1):153. PubMed ID: 36841801
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Oncogene FOXK1 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition.
    Wu Y; Peng Y; Wu M; Zhang W; Zhang M; Xie R; Zhang P; Bai Y; Zhao J; Li A; Nan Q; Chen Y; Ren Y; Liu S; Wang J
    Oncotarget; 2016 Aug; 7(32):51150-51162. PubMed ID: 27223064
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.
    Liu H; Ren G; Wang T; Chen Y; Gong C; Bai Y; Wang B; Qi H; Shen J; Zhu L; Qian C; Lai M; Shao J
    Carcinogenesis; 2015 Apr; 36(4):459-68. PubMed ID: 25750173
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Cten promotes Epithelial-Mesenchymal Transition (EMT) in colorectal cancer through stabilisation of Src.
    Asiri A; Toss MS; Raposo TP; Akhlaq M; Thorpe H; Alfahed A; Asiri A; Ilyas M
    Pathol Int; 2019 Jul; 69(7):381-391. PubMed ID: 31290243
    [TBL] [Abstract][Full Text] [Related]  

  • 85. ELF3 is an antagonist of oncogenic-signalling-induced expression of EMT-TF ZEB1.
    Liu D; Skomorovska Y; Song J; Bowler E; Harris R; Ravasz M; Bai S; Ayati M; Tamai K; Koyuturk M; Yuan X; Wang Z; Wang Y; Ewing RM
    Cancer Biol Ther; 2019; 20(1):90-100. PubMed ID: 30148686
    [No Abstract]   [Full Text] [Related]  

  • 86. Downregulation of iNOS/NO Promotes Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.
    Du Q; Liu S; Dong K; Cui X; Luo J; Geller DA
    Mol Cancer Res; 2023 Feb; 21(2):102-114. PubMed ID: 36306210
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Paired related homoeobox 1, a new EMT inducer, is involved in metastasis and poor prognosis in colorectal cancer.
    Takahashi Y; Sawada G; Kurashige J; Uchi R; Matsumura T; Ueo H; Takano Y; Akiyoshi S; Eguchi H; Sudo T; Sugimachi K; Doki Y; Mori M; Mimori K
    Br J Cancer; 2013 Jul; 109(2):307-11. PubMed ID: 23807160
    [TBL] [Abstract][Full Text] [Related]  

  • 88. miR-296 inhibits the metastasis and epithelial-mesenchymal transition of colorectal cancer by targeting S100A4.
    He Z; Yu L; Luo S; Li M; Li J; Li Q; Sun Y; Wang C
    BMC Cancer; 2017 Feb; 17(1):140. PubMed ID: 28209128
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Unraveling the function of epithelial-mesenchymal transition (EMT) in colorectal cancer: Metastasis, therapy response, and revisiting molecular pathways.
    Sabouni E; Nejad MM; Mojtabavi S; Khoshduz S; Mojtabavi M; Nadafzadeh N; Nikpanjeh N; Mirzaei S; Hashemi M; Aref AR; Khorrami R; Nabavi N; Ertas YN; Salimimoghadam S; Zandieh MA; Rahmanian P; Taheriazam A; Hushmandi K
    Biomed Pharmacother; 2023 Apr; 160():114395. PubMed ID: 36804124
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer.
    Liang WC; Fu WM; Wong CW; Wang Y; Wang WM; Hu GX; Zhang L; Xiao LJ; Wan DC; Zhang JF; Waye MM
    Oncotarget; 2015 Sep; 6(26):22513-25. PubMed ID: 26068968
    [TBL] [Abstract][Full Text] [Related]  

  • 91. CD44v6 expression is related to mesenchymal phenotype and poor prognosis in patients with colorectal cancer.
    Saito S; Okabe H; Watanabe M; Ishimoto T; Iwatsuki M; Baba Y; Tanaka Y; Kurashige J; Miyamoto Y; Baba H
    Oncol Rep; 2013 Apr; 29(4):1570-8. PubMed ID: 23404221
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Detection of FAM172A expressed in circulating tumor cells is a feasible method to predict high-risk subgroups of colorectal cancer.
    Cui CH; Chen RH; Zhai DY; Xie L; Qi J; Yu JL
    Tumour Biol; 2017 Jun; 39(6):1010428317699126. PubMed ID: 28618931
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Molecular portraits of colorectal cancer morphological regions.
    Budinská E; Hrivňáková M; Ivkovic TC; Madrzyk M; Nenutil R; Bencsiková B; Al Tukmachi D; Ručková M; Zdražilová Dubská L; Slabý O; Feit J; Dragomir MP; Borilova Linhartova P; Tejpar S; Popovici V
    Elife; 2023 Nov; 12():. PubMed ID: 37956043
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Mechanically activated ion channel Piezo1 contributes to melanoma malignant progression through AKT/mTOR signaling.
    Zhang S; Cao S; Gong M; Zhang W; Zhang W; Zhu Z; Wu S; Yue Y; Qian W; Ma Q; Wang S; Wang Z
    Cancer Biol Ther; 2022 Dec; 23(1):336-347. PubMed ID: 36112948
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Biological Misinterpretation of Transcriptional Signatures in Tumor Samples Can Unknowingly Undermine Mechanistic Understanding and Faithful Alignment with Preclinical Data.
    Fisher NC; Byrne RM; Leslie H; Wood C; Legrini A; Cameron AJ; Ahmaderaghi B; Corry SM; Malla SB; Amirkhah R; McCooey AJ; Rogan E; Redmond KL; Sakhnevych S; Domingo E; Jackson J; Loughrey MB; Leedham S; Maughan T; Lawler M; Sansom OJ; Lamrock F; Koelzer VH; Jamieson NB; Dunne PD
    Clin Cancer Res; 2022 Sep; 28(18):4056-4069. PubMed ID: 35792866
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Comment on "Identification of EMT-related high-risk stage II colorectal cancer and characterisation of metastasis-related genes".
    Loughrey MB; Fisher NC; McCooey AJ; Dunne PD
    Br J Cancer; 2021 Mar; 124(6):1175-1176. PubMed ID: 33311590
    [No Abstract]   [Full Text] [Related]  

  • 97. Identification of EMT-related high-risk stage II colorectal cancer and characterisation of metastasis-related genes.
    Wang K; Song K; Ma Z; Yao Y; Liu C; Yang J; Xiao H; Zhang J; Zhang Y; Zhao W
    Br J Cancer; 2020 Aug; 123(3):410-417. PubMed ID: 32435058
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Genomics and prognosis analysis of epithelial-mesenchymal transition in colorectal cancer patients.
    Zhang Z; Zheng S; Lin Y; Sun J; Ding N; Chen J; Zhong J; Shi L; Xue M
    BMC Cancer; 2020 Nov; 20(1):1135. PubMed ID: 33228590
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Epithelial-to-mesenchymal transition signature assessment in colorectal cancer quantifies tumour stromal content rather than true transition.
    McCorry AM; Loughrey MB; Longley DB; Lawler M; Dunne PD
    J Pathol; 2018 Dec; 246(4):422-426. PubMed ID: 30105762
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Research Progress of Epithelial-mesenchymal Transition Treatment and Drug Resistance in Colorectal Cancer.
    Ni Q; Li M; Yu S
    Technol Cancer Res Treat; 2022; 21():15330338221081219. PubMed ID: 35435774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.